Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Geoerger

Showing results (21-30 of 179) with videos related to

Pageof 18
Sort By:
Bulletin Du Cancer|January 13, 2004
[Conditionally replicative adenoviruses: a second wind for cancer gene therapy]Jacques Grill, Birgit Geoerger, Martine Lamfers, et al.
BMC Cancer|July 20, 2021
Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulationAnne Catherine Harttrampf, Maria Eugenia Marques da Costa, Aline Renoult, et al.
International Journal of Cancer|August 18, 2010
The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenograftsJochen Rössler, Yann Monnet, Francoise Farace, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2010
Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastomaBirgit Geoerger, Jean-François Brasme, Estelle Daudigeos-Dubus, et al.
Blood Advances|March 8, 2023
Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosisJames A Whitlock, Birgit Geoerger, Ira J Dunkel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2008
Angiogenesis as a target in neuroblastomaJochen Rössler, Melissa Taylor, Birgit Geoerger, et al.
In Vivo (Athens, Greece)|July 2, 2014
Establishment and characterization of new orthotopic and metastatic neuroblastoma modelsEstelle Daudigeos-Dubus, Ludivine LE Dret, Valérie Rouffiac, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2015
Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade gliomaPascal Chastagner, Bénédicte Devictor, Birgit Geoerger, et al.
Anticancer Research|February 7, 2016
Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric MalignanciesSamuel Abbou, Claudia Lanvers-Kaminsky, Estelle Daudigeos-Dubus, et al.
International Journal of Oncology|December 7, 2016
Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumorsEstelle Daudigeos-Dubus, Ludivine Le Dret, Olivia Bawa, et al.
Pageof 18

Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
Bulletin Du Cancer|January 13, 2004
[Conditionally replicative adenoviruses: a second wind for cancer gene therapy]Jacques Grill, Birgit Geoerger, Martine Lamfers, et al.
BMC Cancer|July 20, 2021
Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulationAnne Catherine Harttrampf, Maria Eugenia Marques da Costa, Aline Renoult, et al.
International Journal of Cancer|August 18, 2010
The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenograftsJochen Rössler, Yann Monnet, Francoise Farace, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2010
Anti-insulin-like growth factor 1 receptor antibody EM164 (murine AVE1642) exhibits anti-tumour activity alone and in combination with temozolomide against neuroblastomaBirgit Geoerger, Jean-François Brasme, Estelle Daudigeos-Dubus, et al.
Blood Advances|March 8, 2023
Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosisJames A Whitlock, Birgit Geoerger, Ira J Dunkel, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2008
Angiogenesis as a target in neuroblastomaJochen Rössler, Melissa Taylor, Birgit Geoerger, et al.
In Vivo (Athens, Greece)|July 2, 2014
Establishment and characterization of new orthotopic and metastatic neuroblastoma modelsEstelle Daudigeos-Dubus, Ludivine LE Dret, Valérie Rouffiac, et al.
Cancer Chemotherapy and Pharmacology|June 28, 2015
Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade gliomaPascal Chastagner, Bénédicte Devictor, Birgit Geoerger, et al.
Anticancer Research|February 7, 2016
Polo-like Kinase Inhibitor Volasertib Exhibits Antitumor Activity and Synergy with Vincristine in Pediatric MalignanciesSamuel Abbou, Claudia Lanvers-Kaminsky, Estelle Daudigeos-Dubus, et al.
International Journal of Oncology|December 7, 2016
Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumorsEstelle Daudigeos-Dubus, Ludivine Le Dret, Olivia Bawa, et al.
Pageof 18